AstraZeneca's breast cancer drug fails to meet goal in late-stage trial

15 September 2026 at 12:24 amHyperFast News

#AstraZeneca #Breast Cancer Drug #Clinical Trial #Etcamah #Drug Development

Summary

AstraZeneca's breast cancer drug, Etcamah, failed to meet its primary goal in a late-stage trial, despite receiving U.S. approval for advanced breast cancer a week prior.

AstraZeneca's breast cancer drug fails to meet goal in late-stage trial

Related news

Select what you want to create

Image Post

Prompt to Post

Audio Post

Video Post

Multi-News Carousel

Upload and Schedule

Blog Post

AI Anchor Video

Newsroom FAQs